e-learning
resources
Milan 2017
Sunday, 10.09.2017
Update on community acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia
C. Cilloniz Campos (Barcelona, Spain)
Source:
International Congress 2017 – Update on community acquired pneumonia
Session:
Update on community acquired pneumonia
Session type:
Oral Presentation
Number:
468
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Cilloniz Campos (Barcelona, Spain). Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia. 468
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Viral Sepsis in Adults with Community-Acquired Pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Respiratory Symptoms and Lung Function Depend on Smoking Status and Enviromental Conditions
Source: International Congress 2017 – Smoking, apnoea, infection, allergens and other factors
Year: 2017
Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Clinical Spectrum of Neonatal Respiratory Morbidity in Developing Country
Source: Virtual Congress 2020 – Neonatal and paediatric intensive care: diagnosis, management and outcomes
Year: 2020
Risk Factors for Mortality of COVID-19 Confirmed Cases Admitted at Lung Center of the Philippines
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021
Psychiatric Complications in Patients Receiving Treatment for Multi-Drug Resistant Tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
SOFA (Sequential Organ Failure Assessment) Score As A Predictor Of Moartality In Ventilated Patients With Multi-drug Resistant Bacteremia
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Severity of Bronchiectasis and Lung Functions Related with the Genotype of Primary Ciliary Dyskinesia Patients
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes.
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP)
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept